GlobeNewswire by notified

CORRECTION: Sampo plc: Managers’ Transactions (Magnusson)

Share

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    19 September 2019 at 3:45 pm

CORRECTION: Sampo plc: Managers’ Transactions (Magnusson)

Correction to Sampo plc’s (business code 0142213-3) stock exchange release regarding Managers’ Transactions on 17 September 2019 at 3:35 pm. Due to a technical error, the number of shares was misreported. Below is the corrected notification.
____________________________________________

Person subject to the notification requirement
Name: Magnusson, Torbjörn
Position: Other senior manager
Issuer: Sampo plc
LEI: 743700UF3RL386WIDA22

Notification type: AMENDMENT
Reference number: 743700UF3RL386WIDA22_20190917121931_9

Amendment comment:
Due to a technical error, the number of shares was misreported on 17 September 2019.
____________________________________________

Transaction date: 2019-09-13
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009003305
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION

Transaction details
(1): Volume: 3,302 Unit price: 38.1824 EUR

Aggregated transactions
(1): Volume: 3,302 Volume weighted average price: 38.1824 EUR
____________________________________________

Transaction date: 2019-09-16
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009003305
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION

Transaction details
(1): Volume: 3,316 Unit price: 38.0197 EUR

Aggregated transactions
(1): Volume: 3,316 Volume weighted average price: 38.0197 EUR
____________________________________________

In total, all acquisitions reported above are 6,618 shares.

SAMPO PLC

Jarmo Salonen
Head of Investor Relations and Group Communications
tel. +358 10 516 0030

Distribution:
Nasdaq Helsinki
London Stock Exchange
Financial Supervisory Authority
The principal media
www.sampo.com


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Golar LNG Limited – Q1 2024 results presentation25.4.2024 20:41:48 CEST | Press release

Golar LNG's 1st Quarter 2024 results will be released before the NASDAQ opens on Tuesday, May 28, 2024. In connection with this a webcast presentation will be held at 1:00 P.M (London Time) on Tuesday May 28, 2024. The presentation will be available to download from the Investor Relations section at www.golarlng.com We recommend that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call by clicking on this link. We recommend connecting 10 minutes prior to the call start. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions per participant. a. Listen-only live webcastlink Go to the Investors, Results Centre section at www.golarlng.com and click on the link to "Webcast". To listen to the conference call from the web, y

Vantiva: Appointment of Katleen Vandeweyer as new Lead Independent Director of the Board of Directors25.4.2024 20:30:55 CEST | Press release

Press Release Vantiva: Appointment of Katleen Vandeweyer as new Lead Independent Director of the Board of Directors and presentation of the new composition of its Committees. Paris – April 25, 2024 – Vantiva (Euronext Paris: VANTI) today announced that Katleen Vandeweyer has been named the Lead Independent Director of the Vantiva Board of Directors following a recommendation from the Governance & Corporate Responsibility Committee at the Vantiva Board Meeting on April 24, 2024. Vandeweyer replaces Dominique D’Hinnin, who resigned from his position on April 5 in accordance with the rules governing multiple directorships. Vandeweyer was also appointed to replace D’Hinnin as Vice-Chairperson of the Board. “I would like to sincerely thank Dominique D’Hinnin for his significant contributions to the Vantiva Board and wish him the best in all future endeavors,” said Brian Shearer, Chairperson of Vantiva’s Board of Directors. “Katleen Vandeweyer is a highly accomplished and competent executive

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners25.4.2024 19:30:00 CEST | Press release

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS’ first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major step forward in the transition to a circular economy for plastic and textiles More than 200 guests were present to mark this important occasion: representatives of institutions, partner brands and industrial partners The plant will have a capacity of 50kt/year of prepared waste when operating at full capacity Longlaville (France), Thursday 25 April 2024 (19:30 CET). CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, today celebrated the groundbreaking ceremony for the world's first PET biorecycling plant in the presence of representatives of local authorities, partner brands and industrial partners who all make up CARBIOS’ ecosystem. Located in Longlavi

DECISIONS OF DIGITALIST GROUP PLC’S ANNUAL GENERAL MEETING 25 APRIL 2024 AND THE ORGANIZING MEETING OF THE BOARD OF DIRECTORS25.4.2024 19:00:00 CEST | Press release

DECISIONS OF DIGITALIST GROUP PLC’S ANNUAL GENERAL MEETING 25 APRIL 2024 AND THE ORGANIZING MEETING OF THE BOARD OF DIRECTORS Digitalist Group Oyj Stock Exchange Release 25 April 2024 at 20:00 DECISIONS OF DIGITALIST GROUP PLC’S ANNUAL GENERAL MEETING 25 APRIL 2024 Adoption of the financial statements The Annual General Meeting of Digitalist Group Plc (the “Company”) adopted the Company’s financial statements and consolidated financial statements for the financial period 1 January -31 December 2023. Resolution on the use of the loss shown on the balance sheet and on the distribution of assets The Annual General Meeting resolved that the loss EUR 4,575,895.22 indicated by the financial statements for 2023 be recorded in the Company’s profit and loss account, and that no dividend be paid to shareholders for the financial period 2023. Resolution on the discharge of the members of the Board of Directors and the CEO from liability for the financial period 1 January 2023 to 31 December 2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC25.4.2024 19:00:00 CEST | Press release

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on April 25, 2024, from Atlas Special Opportunities, LLC indicating that as of April 19, 2024, it held 380,755,774 shares of the then outstanding 9,014,821,287 shares, and therefore crossed below the threshold (5%) by virtue of the sale of voting securities. See Annex 1. About Oxurion Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com. Important information about forward-looking statements Certain statements in this press release may

HiddenA line styled icon from Orion Icon Library.Eye